Sarepta Therapeutics Dropped 10% Following FDA News By: Benzinga via Benzinga February 08, 2016 at 13:01 PM EST Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) plunged more than 10 percent on Monday and hit a new 52-week low of $10.60 after ... Read More >> Related Stocks: Sarepta Therapeutics